Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study
Europace · 06.05.2026 · 28 (5)
DOI: 10.1093/europace/euag097 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Europace, online erschienen am 28.04.2026. Verfasst von Emmanouil P Vardas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. Hauptthemen laut MEDLINE: Atrial Fibrillation, MicroRNAs, Catheter Ablation, Circulating MicroRNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Account for Research Funds, ELKE, National and Kapodistrian University of Athens.
Abstract (Originalsprache)
Aims
The identification of reliable biomarkers for atrial fibrillation (AF) recurrence post-catheter ablation remains a clinical challenge. This study aimed to identify circulating microRNAs (miRNAs) associated with post-ablation AF recurrence and examine their underlying molecular pathways using an integrative translational approach. Methods and results This two-phase study included a discovery case-control phase (n = 29) followed by a prospective validation cohort (n = 126). In the discovery phase, 84 miRNAs were quantified via real-time PCR, and candidates were selected using differential expression analysis and machine learning. In the validation phase, five candidate miRNAs (hsa-miR-342-3p, hsa-miR-424-5p, hsa-miR-486-5p, hsa-miR-10b-5p, and hsa-let-7d-5p) were further evaluated to assess their prognostic performance. Pathway enrichment analysis was performed for the most predictive miRNA. Differential expression analysis identified 14 miRNAs to be significantly associated with AF recurrence. In the validation cohort, hsa-miR-10b-5p showed the highest discriminative performance (AUC = 0.96, P < 0.001). Multivariable logistic regression confirmed that lower expression of hsa-miR-10b-5p was an independent predictor of recurrence (OR = 0.06, P < 0.001), significantly improving the baseline clinical model (ΔR = 63.3%). Pathway analysis linked hsa-miR-10b-5p to FOXO signalling, p53 signalling, circadian rhythm and cellular senescence, pathophysiologic mechanisms that are critical to atrial remodelling, and fibrotic persistence.
Conclusion
Down-regulation of circulating hsa-miR-10b-5p was independently associated with AF recurrence after catheter ablation and improved risk discrimination beyond clinical variables. These findings support its potential role as a prognostic biomarker, although further multicentre validation is required before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Electrophysiology, Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.
- 3rd Department of Cardiology, 'Sotiria' Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
- Department of Cardiology, Mitera Hospital, Athens, Greece.
- 1st Department of Cardiology, 'Hippokration' General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
- Laboratory of Biology, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
- Central Diagnostic Laboratories, Hygeia Hospital Athens, Athens 15123, Greece.
ORCID-Profile: Emmanouil P Vardas, Evangelos Oikonomou, Stylianos Tzeis, Panagiotis Theofilis, Dimitrios Asvestas, Dimitrios Charitos, Dimitris Tousoulis
Förderung
- Special Account for Research Funds
- ELKE
- National and Kapodistrian University of Athens
- NKUA
Zitieren
APA
Vardas, E. P., Oikonomou, E., Tzeis, S., Theofilis, P., Gazouli, M., Papadogeorgaki, E., Belogiannis, K., Asvestas, D., Vavouris, E., Charitos, D., & Tousoulis, D. (2026). Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study. Europace, 28(5). https://doi.org/10.1093/europace/euag097
Vancouver
Vardas EP, Oikonomou E, Tzeis S, Theofilis P, Gazouli M, Papadogeorgaki E, et al. Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study. Europace. 2026;28(5). doi:10.1093/europace/euag097
BibTeX
@article{Vardas2026,
author = {Vardas, Emmanouil P and Oikonomou, Evangelos and Tzeis, Stylianos and Theofilis, Panagiotis and Gazouli, Maria and Papadogeorgaki, Eleni and Belogiannis, Konstantinos and Asvestas, Dimitrios and Vavouris, Emmanouil and Charitos, Dimitrios and Tousoulis, Dimitris},
title = {Circulating miR-10b-5p as a candidate biomarker of atrial fibrillation recurrence after catheter ablation: a two-phase translational study},
journal = {Europace},
year = {2026},
volume = {28},
number = {5},
doi = {10.1093/europace/euag097}
}
EUVIMED